These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9401086

  • 1. Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP.
    Wierenga PK, Dillingh JH, Konings AW.
    Br J Haematol; 1997 Dec; 99(3):692-8. PubMed ID: 9401086
    [Abstract] [Full Text] [Related]

  • 2. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3).
    Wierenga PK, Setroikromo R, Vellenga E, Kampinga HH.
    Br J Haematol; 2000 Dec; 111(4):1145-52. PubMed ID: 11167754
    [Abstract] [Full Text] [Related]

  • 3. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK, Konings AW.
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
    Herrmann RP, O'Reilly J, Meyer BF, Lazzaro G.
    Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
    [Abstract] [Full Text] [Related]

  • 7. Survival and characteristics of murine leukaemic and normal stem cells after hyperthermia: a murine model for human bone marrow purging.
    Gidáli J, Szamosvölgyi S, Fehér I, Kovács P.
    Leuk Res; 1990 Sep; 14(5):453-7. PubMed ID: 2345468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide.
    Comte L, Lorgeot V, Bignon J, Volkov L, Dupuis F, Wdzieczak-Bakala J, Praloran V.
    Eur J Clin Invest; 1998 Oct; 28(10):856-63. PubMed ID: 9793000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS, Sikic BI, Blume KG, Chao NJ.
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [Abstract] [Full Text] [Related]

  • 15. In vitro purging of clonogenic leukemic cells from human bone marrow by heat: simulation experiments for autologous bone marrow transplantation.
    Moriyama Y, Hashimoto S, Goto T, Furukawa T, Kishi K, Takahashi M, Shibata A.
    Leuk Res; 1992 Oct; 16(10):973-7. PubMed ID: 1405711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of hyperthermia in bone marrow purging of breast cancer.
    Ingram SS, Samulski T, Dodge R, Prosnitz LR, Peters P, Vredenburgh J.
    Int J Hyperthermia; 1996 Oct; 12(1):21-9. PubMed ID: 8676004
    [Abstract] [Full Text] [Related]

  • 18. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR, Olson AC, Berdel WE, Okamoto S, Glasser L.
    Prog Clin Biol Res; 1990 Oct; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [Abstract] [Full Text] [Related]

  • 19. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
    Moriyama Y, Goto T, Nikkuni K, Aoki A, Furukawa T, Narita M, Koyama S, Kishi K, Takahashi M, Shibata A.
    Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
    [Abstract] [Full Text] [Related]

  • 20. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.
    Carlo-Stella C, Regazzi E, Garau D, Mangoni L, Rizzo MT, Bonati A, Dotti G, Almici C, Rizzoli V.
    Br J Haematol; 1996 Jun; 93(3):551-7. PubMed ID: 8652372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.